Cantor Fitzgerald Downgrades Opiant Pharma (OPNT) to Neutral

November 22, 2022 1:33 PM EST Send to a Friend
Cantor Fitzgerald analyst Brandon Folkes downgraded Opiant Pharma (NASDAQ: OPNT) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login